Equasens (CHIX:EQSP) Operating Margin %: 22.20% (As of Dec. 2025) — 14% Below Median


CHIX:EQSP Equasens CHIX:EQSP
85 GF Score
Price €38.48
GF Value €50.68
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Equasens Operating Margin %?

Equasens CHIX:EQSP 85 Operating Margin % is 22.20% as of Dec. 2025, which is 14% below its 10-year median of 25.90. GuruFocus rates CHIX:EQSP with a GF Score™ of 85/100 and a GF Value™ of €50.68 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Equasens ranks better than 91.32% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Equasens's Operating Income for the six months ended in Dec. 2025 was €26.8 Mil. Equasens's Revenue for the six months ended in Dec. 2025 was €120.5 Mil. Therefore, Equasens's Operating Margin % for the quarter that ended in Dec. 2025 was 22.20%.

Warning Sign:

Equasens operating margin has been in a 5-year decline. The average rate of decline per year is -6%.

The historical rank and industry rank for Equasens's Operating Margin % or its related term are showing as below:

CHIX:EQSp' s Operating Margin % Range Over the Past 10 Years
Min: 20.24   Med: 25.9   Max: 27.16
Current: 20.24


CHIX:EQSp's Operating Margin % is ranked better than
91.32% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 4.845 vs CHIX:EQSp: 20.24

Equasens's 5-Year Average Operating Margin % Growth Rate was -6.00% per year.

Equasens's Operating Income for the six months ended in Dec. 2025 was €26.8 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €47.9 Mil.


Equasens  (CHIX:EQSp) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Equasens Operating Margin % Related Terms


Equasens Operating Margin % Historical Data

* Premium members only.

The historical data trend for Equasens's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Equasens Operating Margin % Chart

Equasens Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.04 26.27 25.37 20.90 20.24

Equasens Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.43 0.00 0.00 18.19 22.20

CHIX:EQSP vs VEEV, BTSG, TEM: Operating Margin % Comparison

For the Health Information Services subindustry, Equasens's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Equasens Operating Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Equasens's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Equasens's Operating Margin % falls into.


CHIX:EQSP
85GF Score
Equasens CHIX:EQSP
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Equasens Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Equasens's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=47.86 / 236.52
=20.24 %

Equasens's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=26.76 / 120.52
=22.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 22.20% mean?
Equasens (CHIX:EQSP) has a Operating Margin % of 22.20% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Equasens and its competitors. This is 14% below median its historical median of 25.90. Over the past decade, Equasens' Operating Margin % has ranged from 20.24 to 27.16. According to the industry distribution chart, Equasens ranks #58 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 8.7%.
Is Equasens' Operating Margin % too high?
Equasens' current Operating Margin % of 22.20% is 14% below median its 10-year median of 25.90. Over the past 10 years, this metric has ranged from a low of 20.24 to a high of 27.16. The Healthcare Providers & Services industry median Operating Margin % is 4.85. Equasens' value of 22.20% is 358.2% above this industry median. Based on the distribution chart, Equasens ranks #58 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Equasens has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Equasens' Operating Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Equasens ranks #58 out of 668 companies for Operating Margin %. This places Equasens in the top 9% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 4.85. Equasens' value of 22.20% is 358.2% above this benchmark. Historically, Equasens' own Operating Margin % has ranged from 20.24 to 27.16 over the past decade. While the company's 10-year median is 25.90 vs. the industry median of 4.85, Equasens has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Equasens's current Operating Margin % of 22.20% is 358.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Equasens and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Equasens's current Operating Margin % is 22.20%, which is 14% below median its own 10-year median of 25.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Equasens stock overvalued right now?
Based on GuruFocus' analysis, Equasens (CHIX:EQSP) is currently considered Modestly Undervalued. The stock's GF Value™ is €50.68, compared to a current price of €38.48 — trading 24.1% below its estimated fair value. The current Operating Margin % is 22.20%, which is 14% below median its 10-year median of 25.90 and 358.2% above the Healthcare Providers & Services industry median of 4.85. Equasens' overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Equasens (CHIX:EQSP), the current Operating Margin % is 22.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Equasens (CHIX:EQSP) Overvalued in 2026?

Based on GuruFocus' analysis, Equasens stock appears to be undervalued. The current stock price of €38.48 is trading 24.1% below its estimated GF Value™ of €50.68. GuruFocus considers Equasens to be Modestly Undervalued.

Key valuation signals for CHIX:EQSP:

  • Operating Margin %: 22.20% (14% below median its 10-year median of 25.90)
  • GF Value™: €50.68 vs. price of €38.48 (24.1% below fair value)
  • GF Score™: 85/100 with 2 warning signs
  • Industry Position: 358.2% above the Healthcare Providers & Services median (#58 of 668)

No single metric tells the full story. See the CHIX:EQSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Equasens Business Description

Address 5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
85GF Score

Get the complete analysis for CHIX:EQSP

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€38.48
Price
€50.68
GF Value